Glenmark launches FDC of Teneligliptin + Pioglitazone + Metformin EP News Bureau Dec 21, 2022 The triple FDC will help improve glycemic control among adults with High HbA1c and high insulin resistance, those whose diabetes…
Successive drug launches will drive growth of NASH market in seven major markets: GlobalData EP News Bureau Nov 23, 2020 The NASH market will undergo a very rapid growth, at a compound annual growth rate (CAGR) of 68.8 per cent from 2019 to 2029
